What does it take to step into a publicly listed CDMO and immediately reposition it for growth in a shifting global market? At Mabion, it starts with people, scientific excellence and a clear commercial vision.

This week on Making It In Manufacturing, Thomas McMann sat down with Gregor Kawaletz, CEO of Mabion, bringing over 20 years of experience in the CDMO space spanning leadership roles across NextPharma, Catalent and Recipharm. Now in the first month as CEO, Gregor shares why this move was about broader impact and how the organisation will be steered into its next phase.

In this episode, Gregor covers:

• The first month as CEO at @Mabion and why “every company is about people”

• The transition from Chief Commercial Officer roles into a CEO position with responsibility for the full organisation

• Growth priorities, pipeline confidence and an upcoming adjusted business model

• The €500,000 innovation initiative and awarding @WPD for novel antibody drug conjugate programmes in oncology

• Regulatory shifts in the biosimilar space and how reduced requirements are expanding patient access

The conversation also explores operating in a more multipolar global environment and why CDMOs must move beyond traditional fee-for-service models toward deeper collaboration and network thinking.

For professionals in biologics, biosimilars or CDMO partnerships, this episode offers strategic insight shaped by experience across NextPharma, Catalent, Recipharm and now at Mabion.

Check out this episode to hear how scientific depth, commercial leadership and organisational alignment can reposition a CDMO for long-term success.

Follow ARTO

LinkedIn: https://www.linkedin.com/company/artotalent

Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng

Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr

TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1

Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575

Website: https://arto-talent.com/

Youtube: https://www.youtube.com/@life_sciences

Gregor Kawaletz - CEO at Mabion

LinkedIn: https://www.linkedin.com/in/gregor-kawaletz-276a4830/

Thomas McMann - Director At ARTO

LinkedIn: https://www.linkedin.com/in/thomas-mcmann-05540a10b/

Timestamps:

00:00 First month as CEO at Mabion

02:19 Two decades in the CDMO space including NextPharma, Catalent and Recipharm

02:42 Moving from CCO to CEO

05:10 Growth strategy and business model evolution

06:57 €500k innovation award and WPD

09:41 Biosimilars regulation and market access

11:04 Navigating a multipolar global supply landscape

12:47 Expanding Mabion’s future offering

#MakingItInManufacturing #ARTOTalent #CDMO #Biologics #Biosimilars #LifeSciences #ManufacturingLeadership

Hosted on Acast. See acast.com/privacy for more information.